Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
National University Corporation Saitama University is currently navigating 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 3 pending office actions indicate the level of patent procurement for the institution. The prosecution involves 2 distinct examiners, which requires the university to manage different sets of examiner expectations. With 2 distinct examiners, the portfolio's progress is subject to multiple examination styles.
All active matters are concentrated within 1 distinct art unit. This focus on 1 distinct art unit suggests the technical focus for the university's current biotechnology and pharmaceutical filings. SPEED, DEQUANTARIUS JAVON is the busiest examiner for this portfolio, currently handling 2 pending office actions. Because SPEED, DEQUANTARIUS JAVON manages the 2 pending office actions, this examiner has an influence on the overall progress of the university's pending applications. The fact that the busiest examiner oversees multiple matters means that the institution's success in this technology area is tied to the determinations of this specific official.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPEED, DEQUANTARIUS JAVON | 2 | 70.0% | +69.2% |
| ROSENAU, DEREK JOHN | 1 | 77.7% | +8.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18164700 | MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SPEED, DEQUANTARIUS JAVON | 56d |
| 18165026 | MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SPEED, DEQUANTARIUS JAVON | 56d |
| 18590487 | ROTATING APPARATUS, MOTOR, AND PUMP | ROSENAU, DEREK JOHN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18164700 | MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SPEED, DEQUANTARIUS JAVON | 56d |
| 18165026 | MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SPEED, DEQUANTARIUS JAVON | 56d |
| Art Unit | Apps |
|---|---|
| 1663 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18590487 | ROTATING APPARATUS, MOTOR, AND PUMP | ROSENAU, DEREK JOHN | — | §102§103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18164700 | MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SPEED, DEQUANTARIUS JAVON | 1663 | §101§112Other | Final Rejection | 56d | Pending | Feb 06, 2023 |
| 18165026 | MUTANT CIS-PRENYLTRANSFERASE (CPT) FAMILY PROTEIN, METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSGENIC PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SPEED, DEQUANTARIUS JAVON | 1663 | §101§112Other | Final Rejection | 56d | Pending | Feb 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial